Mo:re
Focus: Mo:re develops 3D cell culture robotics technology, representing a specialized biotech tools/platforms player headquartered in Hamburg, Germany.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Mo:re?
AI assessmentMo:re offers high-risk, high-potential-upside opportunity for biotech professionals comfortable with early-stage visibility challenges and seeking equity-driven growth in lab automation.
Why Work Here
- Early-stage platform company with potential to establish market category in 3D cell culture automation
- Perfect visa sponsorship record: 3/3 H1B approvals in 2023 with zero denials signals strong employer standing
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Mo:re
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.